Nuray Chemicals Profile
Key Indicators
- Authorised Capital ₹ 24.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 23.84 Cr
as on 23-10-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 58.25 Cr
as on 23-10-2024
- Revenue 10.27%
(FY 2023)
- Profit -77.34%
(FY 2023)
- Ebitda -43.64%
(FY 2023)
- Net Worth 1.64%
(FY 2023)
- Total Assets -1.32%
(FY 2023)
About Nuray Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 24.00 Cr and a paid-up capital of Rs 23.84 Cr.
The company currently has active open charges totaling ₹13.00 Cr. The company has closed loans amounting to ₹58.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jaganathan Jayaseelan, Shanmugam Muthusamy, Ayyavu Rajavel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110TN2012PTC086320
- Company No.
086320
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nuray Chemicals Private Limited offer?
Nuray Chemicals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Nuray Chemicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shanmugam Muthusamy  | Director | 18-Jan-2013 | Current |
Jaganathan Jayaseelan  | Director | 14-Jun-2012 | Current |
| Ayyavu Rajavel | Alternate Director | 14-Jun-2012 | Current |
| Ravi Kulandasamy | Director | 04-Mar-2020 | Current |
Financial Performance of Nuray Chemicals.
Nuray Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.27% increase. The company also saw a substantial fall in profitability, with a 77.34% decrease in profit. The company's net worth moved up by a moderate rise of 1.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuray Chemicals?
In 2023, Nuray Chemicals had a promoter holding of 90.28% and a public holding of 9.72%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saimirra Innopharm Private LimitedActive 24 years 9 monthsJaganathan Jayaseelan, Shanmugam Muthusamy and 1 more are mutual person
Inventz Life Sciences Private LimitedActive 7 years 9 monthsJaganathan Jayaseelan is a mutual person
Delvin Surgicals Private LimitedActive 9 years 4 monthsJaganathan Jayaseelan and Ayyavu Rajavel are mutual person
Scitus Pharma Services Private LimitedActive 7 years 2 monthsShanmugam Muthusamy and Ayyavu Rajavel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Dec 2023 | ₹6.00 Cr | Open |
Others Creation Date: 29 Aug 2017 | ₹7.00 Cr | Open |
Others Creation Date: 01 Oct 2021 | ₹1.75 Cr | Satisfied |
How Many Employees Work at Nuray Chemicals?
Nuray Chemicals has a workforce of 336 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuray Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuray Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
